Document Detail


Oxygen and placental vascular development.
MedLine Citation:
PMID:  10635006     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Human embryogenesis takes place in a hypoxic environment because the trophoblast shell excludes entry of maternal blood. The first fetal-placental villi develop as trophoblast sprouts. These are invaded by allantoic mesoderm to form secondary villi and are transformed, by vasculogenesis, into tertiary villi. The placental barrier to maternal blood is gradually breached between 8-12 weeks of gestation, due to invasion of placental-bed uteroplacental spiral arteries by the extravillous trophoblast (EVT). Placental oxygen tension thus rises and a phase of branching angiogenesis continues until 24 weeks. Thereafter a gradual shift takes place favoring non-branching angiogenesis. Gas-exchanging terminal villi thus form which are essential for rapid fetal growth and development of a high-flow, low-resistance fetal-placental circulation. Inadequate invasion of the uteroplacental spiral arteries by EVT results in placental ischemia and the development of obstetrical complications--preeclampsia and/or intrauterine growth restriction (IUGR). Placental villi often show evidence of continued branching angiogenesis, as is the case with anemic pregnancy, and pregnancy at high altitude. These structural alterations may reflect continued hypoxia-driven activity of vascular endothelial growth factor (VEGF). By contrast, a minority of severe early-onset IUGR pregnancies exhibit reduced fetal-placental blood flow with elongated maldeveloped villous capillaries. Placenta-like growth factor (PIGF) expression is increased while trophoblast proliferation is reduced, suggesting "hyperoxia" in the placental villous tree. IUGR may thus have two phenotypes--a more common hypoxic and a rarer hyperoxic type. While this concept is gaining acceptance, we have no insight as to the initiating mechanism(s).
Authors:
J C Kingdom; P Kaufmann
Related Documents :
7959636 - Regulation of maternal insulin-like growth factor i by placental growth hormone in preg...
14715876 - A longitudinal study of intrauterine growth and the placental growth hormone (gh)-insul...
20420276 - Correlations of fetal-maternal outcomes and first trimester 3-d placental volume/3-d po...
15042006 - Maternal insulin-like growth factor-i levels (igf-i) reflect placental mass and neonata...
16613886 - Single versus double embryo transfer: cost-effectiveness analysis alongside a randomize...
3555216 - Advantages to female rodents of male-induced pregnancy disruptions.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Advances in experimental medicine and biology     Volume:  474     ISSN:  0065-2598     ISO Abbreviation:  Adv. Exp. Med. Biol.     Publication Date:  1999  
Date Detail:
Created Date:  2000-02-03     Completed Date:  2000-02-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0121103     Medline TA:  Adv Exp Med Biol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  259-75     Citation Subset:  IM    
Affiliation:
Department of Obstetrics & Gynecology, University of Toronto, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Embryonic and Fetal Development / physiology*
Female
Fetal Growth Retardation / physiopathology
Gestational Age
Humans
Ischemia / physiopathology
Maternal-Fetal Exchange / physiology
Neovascularization, Physiologic*
Oxygen / physiology*
Placenta / blood supply*
Pre-Eclampsia / physiopathology
Pregnancy
Trophoblasts / physiology*
Chemical
Reg. No./Substance:
7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hypoxia induces cell-specific changes in gene expression in vascular wall cells: implications for pu...
Next Document:  Vascular growth in hypoxic skeletal muscle.